| Literature DB >> 32536719 |
Mery Vet George De la Rosa1,2, Roberto Santiago2,3, Joseph Malavé Romero2,4, Jorge Duconge1, Jean-Christophe Monbaliu5, Vilmalí López-Mejías2,6, Torsten Stelzer1,2.
Abstract
The solubility of warfarin sodium isopropanol solvate (WS·IPA), a widely used anticoagulant, was determined at temperatures ranging from 278.15 to 333.15 K in four pure solvents (acetone, ethanol, IPA, and water), five binary solvent mixtures (IPA + acetone, IPA + ethanol, IPA + water, IPA + heptane, and IPA + hexane), and five ternary solvent mixtures (IPA + acetone + heptane, IPA + acetone + hexane, IPA + ethanol + heptane, IPA + ethanol + hexane, and IPA + water + heptane) using the polythermal method. It was demonstrated that the solubility of WS·IPA increases with increasing temperature in the pure solvents and at constant solvent composition in the solvent mixtures. In addition, the solubility of WS·IPA in IPA increases with increasing content of acetone, ethanol, and water, which act as cosolvents, and decreases with increasing content of heptane and hexane, which act as antisolvents. The experimental solubility data of WS·IPA in pure solvents and binary and ternary solvent mixtures were correlated using the modified Apelblat and λh model equations. The correlated solubility data agree with the experimental data based on the relative deviation and the average relative deviation (ARD %) values. Thus, the correlated and experimentally derived solubility data of WS·IPA provide a pathway to engineer advanced pharmaceutical crystallization processes for WS·IPA.Entities:
Year: 2019 PMID: 32536719 PMCID: PMC7291792 DOI: 10.1021/acs.jced.8b00977
Source DB: PubMed Journal: J Chem Eng Data ISSN: 0021-9568 Impact factor: 2.694